Skip to main content

Table 1 Patient characteristics for patients treated at GUH and CMSE Namur

From: Factors modifying the risk for developing acute skin toxicity after whole-breast intensity modulated radiotherapy

  

GUH

CMSE Namur

(n = 282)

(n = 95)

Age (years)

   
 

Median

57.5

59.0

Range

30-82

35-82

Bra cup size

   
 

Small

A

13 (4.6)

3 (3.2)

 

B

85 (30.2)

33 (34.7)

 

C

101 (35.8)

34 (35.8)

Large

D

53 (18.8)

16 (16.8)

 

E

16 (5.7)

5 (5.3)

 

F

7 (2.5)

3 (3.2)

 

G + H

2 (0.6)

1 (1.0)

Missing

 

5

0

BMI

   
 

Median

25.5

26

Range

16-50

16-38

 

Missing

2

0

Menstruation

   
 

No

235 (83.3)

76 (80.0)

 

Yes

45 (16.0)

18 (18.9)

 

Missing

2

1

Smoking during RT

   
 

No

244 (86.5)

79 (83.2)

 

Yes

35 (12.4)

16 (16.8)

 

Missing

3

0

Diabetes

   
 

No

254 (90.1)

84 (88.4)

 

Yes

22 (7.8)

11 (11.6)

 

Missing

6

0

Hypertension

   
 

No

196 (69.5)

66 (69.5)

 

Yes

81 (28.7)

29 (30.5)

 

Missing

5

0

Fractionation

   
 

Normo

0

45 (47.4)

 

Hypo

282

50 (52.6)

 

Missing

0

0

Treatment position

   
 

Supine

195 (69.1)

95 (100.0)

 

Prone

87 (30.9)

0

 

Missing

0

0

Boost

   
 

No

64 (22.7)

7 (7.4)

 

Yes

218 (77.3)

88 (92.6)

 

Missing

0

0

Nodal irradiation

   
 

No

241 (85.5)

87 (80.6)

 

Yes

41 (14.5)

21 (19.4)

 

Missing

0

0

Hormonal therapy

   
 

No

46 (16.3)

25 (26.3)

 

Concomitant

236 (83.7)

7 (7.4)

 

Sequential (after IMRT)

0

63 (66.3)

 

Missing

0

0

Chemotherapy

   
 

No

188 (66.7)

55 (57.9)

 

Yes

94 (33.3)

40 (42.1)

 

Missing

0

0

Trastuzumab

   
 

No

257 (91.1)

83 (87.4)

 

Yes

25 (8.9)

12 (12.6)

 

Missing

0

0

  1. Abbreviations: GUH Ghent University Hospital, CMSE ST.-Elisabeth Clinic and Maternity, BMI Body Mass Index.
  2. Data are given as no. (%) unless otherwise indicated.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us